Quintara Biosciences

Overview

Quintara Biosciences describes itself as the "Home of Sequencing" and sells fee-for-service DNA and RNA services to life science customers. The company states it was founded in 2005.

Sequencing services

• Sanger sequencing, nanopore sequencing, next-generation sequencing (Illumina), and PacBio sequencing
• Whole plasmid, whole amplicon, whole genome, hybrid whole genome, and amplicon sequencing
• Bulk RNA-seq, single-cell sequencing, genotyping validation, and gene edit and genotype sequencing

Molecular biology and gene synthesis

• Gene synthesis and cloning, plasmid preparation, and AAV plasmid solutions
• The AAV plasmid page describes ITR sequencing and a four-layer quality approach intended to support preclinical-grade AAV plasmids for gene therapy programs

mRNA one-stop solutions

• Sequence optimization for IVT transcription and expression
• Gene synthesis and cloning into IVT-ready vectors, with proprietary 5′ and 3′ UTR designs and 60A or 100A poly(A) options
• Plasmid preparation and linearization
• IVT mRNA synthesis, with custom production or off-the-shelf mRNA products
• LNP encapsulation, with customer-supplied or validated lipid options and characterization of particle size, PDI, and encapsulation efficiency

Antibody and protein

• Listed offerings include a high-throughput platform for recombinant antibodies, bispecific antibodies, and recombinant proteins

Reagents

• QuinDye™ Terminator, eGFP mRNA (m1Ψ), Fluc mRNA (m1Ψ), and hNoggin